Brief Description
Juvena Therapeutics is discovering novel protein-based therapeutics that promote tissue regeneration in the elderly and treat various age-related diseases. The company's AI-enabled discovery platform maps the therapeutic potential of secreted proteins, with the goal of accelerating the discovery of treatments that help individuals maintain and even improve their muscle mass and function, which is commonly affected by aging.
The company was born out of CEO and co-founder Hanadie Yousef's research as a PhD student at UC Berkeley, in the laboratories of Drs. David Schaffer and Irina Conboy, studying how protein signaling changes with aging and affects the ability of tissues to maintain health.
Inventors
Michael Conboy, Irina Conboy, David Schaffer, and Hanadie Yousef
Company Founders
Hanadie Yousef (UC Berkeley, Ph.D. ’13, Doctor of Philosophy, Molecular & Cell Biology), Jeremy O’Connell (Ph.D.), Neil Berkley, Joe Betts-Lacroix
Timeline
- 2017. Company founded